|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334 IDR | -1.76% |
|
+1.83% | +35.77% |
PT Diagnos Laboratorium Utama Tbk reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 143,827.88 million compared to IDR 250,831.44 million a year ago. Net income was IDR 12,159.8 million compared to IDR 63,975.4 million a year ago.
Basic earnings per share from continuing operations was IDR 9.72784 compared to IDR 51.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.77% | 25.69M | |
| -18.11% | 8.35B | |
| +45.10% | 3.58B | |
| -8.06% | 2.47B | |
| -38.71% | 2.46B | |
| -7.96% | 2.36B | |
| -13.72% | 1.78B | |
| -19.73% | 1.53B | |
| -40.78% | 1.21B | |
| +8.32% | 1.12B |
PT DIAGNOS LABORATORIUM UTAMA TBK 
